Literature DB >> 16438648

HIV type 1 persistence in CD4- /CD8- double negative T cells from patients on antiretroviral therapy.

Kelly M Cheney1, Raman Kumar, Adrian Purins, Linda Mundy, Wendy Ferguson, David Shaw, Christopher J Burrell, Peng Li.   

Abstract

The establishment of reservoirs of latently infected cells is thought to contribute to the persistence of HIV-1 infection in the host. Studies so far have mainly focused on the long-lived reservoir of HIV-infected resting CD4+ T cells. A discrete population of HIV-infected CD4-/CD8- double negative (DN) T cells has recently been shown to exist and may also play a role in HIV-1 persistence. DN T cells are CD3 positive, either TCRalphabeta or TCRgammadelta positive, but lack both CD4 and CD8 surface markers. We developed a novel, magnetic bead column-based cell fractionation procedure for isolating >99% pure DN T cells. CD4+, CD8+, and DN T cells were purified from 23 samples of a cohort of 18 HIV-1-infected patients. Each cell fraction was analyzed for levels of total and integrated HIV-1 DNA. A correlation was observed between the presence of HIV-1 DNA in the DN T cell fraction and plasma viral load (VL). Using a micrococulture technique, we saw an initial release of virus from DN T cells of a patient with high VL. Analysis of env and nef sequence data suggested that the HIV-1 present in CD4+ and DN T cells originated from a common infecting strain. Different from the published literature, we have demonstrated the presence of HIV-1 DNA in DN T cells only in patients who are experiencing HAART failure. While these cells may have a limited role in viral persistence in high VL patients, our results suggest DN T cells are unlikely to be a major reservoir in patients on HAART with clinically undetectable plasma viral RNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16438648     DOI: 10.1089/aid.2006.22.66

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  9 in total

1.  Human CD4- 8- T cells are a distinctive immunoregulatory subset.

Authors:  Mei-Chuan Huang; Kalpesh Patel; Dennis D Taub; Dan L Longo; Edward J Goetzl
Journal:  FASEB J       Date:  2010-02-12       Impact factor: 5.191

2.  CD4-like immunological function by CD4- T cells in multiple natural hosts of simian immunodeficiency virus.

Authors:  Carol Vinton; Nichole R Klatt; Levelle D Harris; Judith A Briant; Brigitte E Sanders-Beer; Richard Herbert; Ruth Woodward; Guido Silvestri; Ivona Pandrea; Cristian Apetrei; Vanessa M Hirsch; Jason M Brenchley
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

Review 3.  Double-negative T cells during HIV/SIV infections: potential pinch hitters in the T-cell lineup.

Authors:  Vasudha Sundaravaradan; Kiran D Mir; Donald L Sodora
Journal:  Curr Opin HIV AIDS       Date:  2012-03       Impact factor: 4.283

4.  Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy.

Authors:  Marta Massanella; Wendy Bakeman; Pasiri Sithinamsuwan; James L K Fletcher; Nitiya Chomchey; Somporn Tipsuk; Thep Chalermchai; Jean-Pierre Routy; Jintanat Ananworanich; Victor G Valcour; Nicolas Chomont
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

5.  Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.

Authors:  J M Carr; K M Cheney; C Coolen; A Davis; D Shaw; W Ferguson; G Chang; G Higgins; C Burrell; P Li
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

6.  Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.

Authors:  Philipp Kaiser; Beda Joos; Barbara Niederöst; Rainer Weber; Huldrych F Günthard; Marek Fischer
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

7.  Conversion of effector CD4+ T cells to a CD8+ MHC II-recognizing lineage.

Authors:  Elizabeth Robins; Ming Zheng; Qingshan Ni; Siqi Liu; Chen Liang; Baojun Zhang; Jian Guo; Yuan Zhuang; You-Wen He; Ping Zhu; Ying Wan; Qi-Jing Li
Journal:  Cell Mol Immunol       Date:  2020-02-17       Impact factor: 11.530

8.  HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?

Authors:  Deanna A Kulpa; Nicolas Chomont
Journal:  J Virus Erad       Date:  2015-04

9.  Impact of the SCF signaling pathway on leukemia stem cell-mediated ATL initiation and progression in an HBZ transgenic mouse model.

Authors:  Wakako Kuribayashi; Kazuya Takizawa; Kenji Sugata; Madoka Kuramitsu; Haruka Momose; Eita Sasaki; Yuki Hiradate; Keiko Furuhata; Yoshihisa Asada; Atsushi Iwama; Masao Matsuoka; Takuo Mizukami; Isao Hamaguchi
Journal:  Oncotarget       Date:  2016-08-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.